Recipients of the Drug Therapy Research Award

“Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review”
Winning article authors: Kirk E. Evoy, Pharm.D., Megan D. Morrison, Pharm.D., Stephen R. Saklad, Pharm.D. 
Drugs 2017;77(4):403-426.

“Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs. 2011”
Dima M. Qato, Pharm.D., M.P.H., Ph.D., Jocelyn Wilder, M.P.H., L. Philip Schumm, M.S., Victoria Gillet, B.S., G. Caleb Alexander, M.D., M.S.
JAMA Intern Med. 2016 Apr;176(4):473-82. doi: 10.1001/jamainternmed.2015.8581
Watch the awards video now.

“A Multicenter Evaluation of Prolonged Empiric Antibiotic Therapy in Adult ICUs in the United States”
Zachariah Thomas, Pharm.D., Farooq Bandali, Pharm.D., Jayashri Sankaranarayanan, M.Pharm., Ph.D., Thomas Reardon, M.A., Keith M. Olsen, Pharm.D.
Crit Care Med. 2015 Dec;43(12):2527-34.
Watch the awards video now


“Empiric Potassium Supplementation and Increased Survival in Users of Loop Diuretics”
Charles E. Leonard, Pharm.D., M.S.C.E., Hanieh Razzaghi, M.P.H., Cristin P. Freeman, M.P.H., M.B.E., Jason A. Roy, Ph.D., Craig W. Newcomb, M.S., and Sean Hennessy, Pharm.D., Ph.D.
PLOS ONE. 2014; 9:e102279.   
University of Pennsylvania, Perelman School of Medicine
Philadelphia, PA
Watch the awards video now.

“Type of Stress Ulcer Prophylaxis and Risk of Nosocomial Pneumonia in Cardiac Surgical Patients: Cohort Study”
Brian T. Bateman, M.D., M.S.c., Katsiaryna Bykov, Pharm.D., M.S., Niteesh K. Choudhry, M.D., Ph.D., Sebastian Schneeweiss, M.D., Sc.D., Joshua J. Gagne, Pharm.D., Sc.D., Jennifer M. Polinski, Sc.D., M.P.H., Jessica M. Franklin, Ph.D., Michael Doherty, M.S., Michael A. Fischer, M.D., M.S., and Jeremy A. Rassen, Sc.D.
BMJ. 2013; 19:347.
Brigham and Women's Hospital and Harvard Medical School
Boston, MA
Watch awards video.

“Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding”
Daniel M. Witt, Pharm.D., Thomas Delate, Ph.D., David A. Garcia, M.D., Nathan P. Clark, Pharm.D., Elaine M. Hylek, M.D., M.P.H., Walter Ageno, M.D., Francesco Dentali, M.D., and Mark A. Crowther, M.D.
Arch Intern Med. 2012; 172:1484-91.
Kaiser Permanente Colorado
Aurora, Colo.
Watch Dr. Witt accept his award.

“Oral Antidiabetic Drugs for the Prevention of Type 2 Diabetes”
Olivia J. Phung, Pharm.D., Nitesh A. Sood, M.D., Bruce E. Sill, Pharm.D., and Craig I. Coleman, Pharm.D.
Diabet Med. 2011; 28:948-64.
Western University of Health Sciences
Pomona, Calif.
Watch Dr. Phung accept her award.

“Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease”
Rhonda M. Cooper-DeHoff, Pharm.D., M.S., Yan Gong, Ph.D., Eileen M. Handberg, Ph.D., Anthony Bavry, M.D., M.P.H., Scott Denardo, M.D., George Bakris, M.D., and Carl Pepine, M.D.
JAMA 2010; 304:61-68.
University of Florida
Gainesville, Fla.
Watch Dr. Cooper-DeHoff accept her award.

"Adverse Outcomes Demonstrated for Drotrecogin Alfa (Activated) in Septic Patients With Baseline Bleeding Precautions"
Chris A. Gentry, Pharm.D., BCPS, Kristin Busse, Pharm.D., Bhanu Sud, M.D., and Douglas Drevets, M.D.
Critical Care Medicine 2009; 37:19-25.
Oklahoma City VA Medical Center
Oklahoma City, Okla.

“Safety and Efficacy of a Fish-Oil-Based Fat Emulsion in the Treatment of Parenteral Nutrition-Associated Liver Disease”
Kathleen M. Gura, Pharm.D., BCNSP, Sang Lee, M.D., Clarissa Valim, M.D., Sc.D., Jing Zhou, M.S., Sendia Kim, M.D., Biren P. Modi, M.D., Danielle A. Arsenault, B.S., Robbert A.M. Strijbosch, B.S., Suzanne Lopes, B.S.N., Christopher Duggan, M.D., M.P.H., Mark Puder, M.D., Ph.D. 
Pediatrics 2008; 121:3:e678-86.
Children's Hospital Boston
Boston, Mass.

“Impact of Statin Dosing Intensity of Transaminase Creatine Kinase”
Krista M. Dale, Pharm.D., C. Michael White, Pharm.D., Nickole N. Henyan, Pharm.D., Jeffrey Kluger, M.D., and Craig I. Coleman, Pharm.D.
The American Journal of Medicine 2007; 120:706-12.
University of Connecticut School of Pharmacy
Storrs, CT
Hartford Hospital
Hartford, CT

“Time Until Initiation of Fluconazole Therapy Impacts Mortality in Patients With Candidemia: A Multi-Institutional Study”
Kevin W. Garey, Pharm.D., M.S., Milind Rege, M.S., Manjunath P. Pai, Pharm.D., Dana E. Mingo, Pharm.D., Katie J. Suda, Pharm.D., Robin S. Turpin, Ph.D., and David T. Bearden, Pharm.D.
Clinical Infectious Diseases 2006; 43(July1):25-31.
University of Houston College of Pharmacy and St. Luke’s Episcopal Hospital
Houston, TX

“The Impact of ACE Inhibitors or Angiotension II Type 1 Receptor Blockers on the Development of New-Onset Type 2 Diabetes”
Craig I. Coleman, Pharm.D., C. Michael White, Pharm.D., FCCP, FCP, Effie L. Kuti, Pharm.D., Michael J. Kardas, Pharm.D., and Michael Lindberg, M.D.
Diabetes Care 2005; 28:2261-2266
University of Connecticut School of Pharmacy, Storrs, CT
Hartford Hospital, Hartford, CT


“Electrocardiographic and Hemodynamic Effects of a Multicomponent Dietary Supplement Containing Ephedra and Caffeine: A Randomized Controlled Trial”
Brian F. McBride, Pharm.D.; Angeliki K. Karapanos, R.Ph.; Agnes Krudysz, BSN, R.Ph.; Jeffrey Kluger, M.D.; Craig I. Coleman, Pharm.D.; C. Michael White, Pharm.D.
JAMA 2004; 291:216-221
University of Connecticut Schools of Pharmacy and Medicine, Storrs and Farmington, CT
Hartford Hospital, Hartford, CT

“Intravenous Plus Oral Amiodarone, Atrial Septal Pacing, or Both Strategies to Prevent Post-Cardiothoracic Surgery Atrial Fibrillation: The Atrial Fibrillation Suppression Trial II (AFIST II)”
C. Michael White, Pharm.D.; Michael F. Caron, Pharm.D.; James S. Kalus, Pharm.D.; Heidi Rose, R.N.; Jessica Song, Pharm.D.; Prabashni Reddy, Pharm.D.; Robert Gallagher, M.D., Jeffrey Kluger, M.D.
Circulation, 2003; 108[suppl II]:II-200-II-206.
Hartford Hospital, Hartford, CT

"Association Between CYP2CP Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy"
Michelle K. Higashi, Ph.D.; David L. Veenstra, Pharm.D., Ph.D.; L. Midori Kondo, Pharm.D.; Ann K. Wittkowsky, Pharm.D.; Sengkeo L. Srinouanprachanh, B.S.; Fred M. Farin, M.D.; and Allan E. Rettie, Ph.D.
Pharmaceutical Outcomes Research and Policy Program
Universtiy of Washington, Seattle

"Oral Amiodarone for Prevention of Atrial Fibrillation After Open-Heart Surgery, the Atrial Fibrillation Suppression Trial (AFIST): A Randomised, Placebo-Controlled Trial"
Satyendra Giri, M.D., Brigham & Women's Hospital, Harvard University, Boston MA; C. Michael White, Pharm.D., Hartford Hospital, Hartford, CT; Alisha B. Dunn, Pharm.D., Northeastern University, Boston, MA; Kathy Felton, R.N., Linda Freeman-Bosco, R.N., and Prabashni Reddy, Pharm.D., Hartford Hospital, Hartford, CT; James P. Tsikouris, Pharm.D., Texas Tech University, Lubbock; and Heather A. Wilcox, R.N., and Jeffrey Kluger, M.D., Hartford Hospital, Hartford, CT.
The Lancet 2001; 357 [March 17]:830-836.

"Cyclosporine-Drug Interactions and the Influence of Patient Age"
Jennifer Lill, Pharm.D.
University of Washington Medical Center
Larry A. Bauer, Pharm.D.; John R. Horn, Pharm.D.; and Philip D. Hasten, Pharm.D.
American Journal of Health-System Pharmacy, 2000; 57:1579-84.
Department of Pharmacy and Laboratory Medicine
University of Washington, Seattle

"An Assessment of the Safety of Short-Term Amiodarone Therapy in Cardiac Surgical Patients with Fentanyl-Isoflurane Anesthesia"
Michael White, Pharm.D.; Alisha Dunn, Pharm.D.; James Tsikouris, Pharm.D.; Witold Wabertski, M.D.; Kathy Felton, R.N.; Linda Freeman-Bosco, R.N.; Satyendra Giri, M.D.; and Jeffery Kluger, M.D.
Anesthesia and Analgesia, 1999; 89:585-9.
Hartford Hospital
Hartford, CT

"Efficacy of Ondansetron and Prochlorperazine for the Prevention of Postoperative Nausea and Vomiting After Total Hip Replacement or Total Knee Replacement Procedures"
Jack J. Chen, Pharm.D.; and David G. Frame, Pharm.D.
Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL
T. Jeffrey White, Pharm.D., University of Southern California School of Pharmacy, Los Angeles, CA
Arch Intern Med. 1998; 158:2124-8

"Pharmacodynamics of Levofloxacin: A New Paradigm for Early Clinical Trials"
Sandra L. Preston, Pharm.D., George L. Drusano, M.D., Adam L. Berman, Albany Medical Center, Albany, NY; Cynthia L. Fowler, M.D., Andrew T. Chow, Ph.D., Bruce Dornseif, Ph.D., VeronicaReichl, R.N., Jaya Natarajan, Ph.D., and Michael Corrado, M.D., Robert Wood Johnson Pharmaceutical Research Institute, Raritan, NJ.
Journal of the American Medical Association, January 14, 1998.

No Drug Therapy Research Award was given in 1997.

"Safety and Cost of Rapid IV Injection of Famotidine in Critically Ill Patients"
Douglas N. Fish, Pharm.D.
American Journal of Health-System Pharmacy, 1995; 52:1889-94.
University of Colorado Health Sciences Center
Denver, CO

"Effect of Pharmaceutical Formulation of Diltiazem on the Utilization of Medicaid and Health Maintenance Organization Services"
David A. Sclar, Tracy L. Skaer, and Linda M. Robison, Washington State University, Pullman; Genevieve C. Tessier, Nordic Merrell Dow Research, Inc., Laval, Quebec, Canada; and Randall F. Legg and Neil L. Nemec, Qual-Med Health Plan of Washington, Spokane.
Current Therapeutic Research, October 1994.

"Comparison of Population Pharmacokinetic Models for Gentamicin in Spinal Cord-Injured and Able-Bodied Patients"
Thomas M. Gilman, Sherry R. Brunneman, and Jack L. Segal.
Antimicrobial Agents and Chemotherapy, January 1993, pp. 93-99.
Veterans Affairs Medical Center
Long Beach, CA

"Cefuroxime by Continuous Infusion: A New Standard of Care?"
John A. Zeisler, John D. McCarthy, William A. Richelieu, and Michael B. Nichol.
Infections in Medicine, November 1992, pp. 54-60.
Presbyterian Intercommunity Hospital
Whittier, CA

Prior to the establishment of the Drug Therapy Research Award and the Professional Practice Research Award in 1993, there was only one category: the Research Award. To see a list of the recipients of the Research Award, 1971 - 1992), click here.